top of page
Our Philosophy
Every biological product carries the evidence of what it is
Every living species carries a molecular record of what it is, written in its DNA. A jar of honey carries the pollen of the plants the bees foraged, a fish fillet carries the genetic signature of the species it came from, and a botanical supplement capsule carries the DNA of whatever plants went into it. That molecular record belongs inseparably to a material, product, or ingredient and sits underneath every label, waiting to answer the question: what is this, actually?
Lumicore was founded to make the record readable for the people who need it most.
The problem we exist to solve is older than lab testing
When you buy a bottle of honey, an herbal supplement, a fillet of fish, a pound of beef, a yard of cotton, a piece of imported wood, or any other product on your market shelf sourced from a supplier you have never visited, what you are trusting is a claim. Somebody wrote something on a label, a chain of institutions signed off on it, and you are trusting that every link did its job honestly and competently. When the system works, which is most of the time, you get what the label says. When it fails, the failures are significant. Food fraud costs $40 to $50 billion a year globally. Seafood mislabeling reaches 20 to 40 percent in some markets. Honey is one of the most adulterated foods in the world. Supplements have been documented, repeatedly, containing almost nothing of what their labels promise. Premium textiles get blended below the line of detection. High-value timber crosses borders under false species names.
Every one of these failures happened inside systems that had certifications, inspectors, and paper trails designed to prevent them. A certification verifies a process. A paper trail verifies paper. A brand reputation verifies a company's history. Each of these mechanisms is evaluating a representation of the material rather than the material itself, and representations can be wrong, outdated, falsified, or inconsistent about the aspects that matter most. This is the architecture of modern commerce, and it works because verifying every claim personally has never been feasible at the scale human civilization requires. We, as a civilization, built institutional trust as connective tissue instead. That connective tissue is showing its age, and the gap between what molecular verification can provide and what existing systems actually deliver is one of the largest and most consequential gaps in global commerce today.
These structural problems are intensifying. Our products pass through more hands and across more borders than at any point in history in a moment when we care more deeply than ever about what we put in our bodies and use in our lives. Synthetic biology has reached the point where biologically synthesized materials are present in supply chains, pressure on supplement, food, and pharmaceutical ingredient quality is sharpening, and the need for verification at the genomic level has been growing for years. The capability to provide it has only recently caught up.
Every node in a biological supply chain has a verification question
A grower verifies seed stock. A processor verifies raw materials. A distributor verifies shipments. A retailer verifies what reaches the shelf. A regulator verifies what is in the market. An importer verifies what crossed the border. An exporter verifies what they sent. Each one is a different person with a different version of the same problem, and each one has structural reason to want an answer the supply chain itself cannot provide.
We read DNA because DNA is the evidence
DNA sequencing identifies biological species directly from the material itself. Species that look identical under a microscope can be distinguished through their genetic code in hours. Adulterants present at low concentrations can be detected alongside the primary ingredient. Substitutions that would pass visual or chemical inspection leave DNA signatures that genomic analysis is designed to find. The science underneath this work has been published and peer-reviewed for more than two decades. What has changed is access. Sequencing technology has become small, fast, and affordable enough that the verification once reserved for government laboratories and major research institutions can be performed for anyone who needs it.
Most DNA testing for product authenticity uses targeted methods that look for specific species chosen in advance, which works well when the question is narrow and the expected answer falls within a defined set of options. We built our laboratory on whole genome and metagenomic sequencing as a foundation because these approaches can answer questions that targeted methods alone may not reach, including what a sample reveals about itself when no one has decided in advance what to ask. Targeted approaches, including PCR based methods, remain part of our toolkit for cases where a focused answer is what the question calls for, or where sample condition favors fragment amplification over long read sequencing.
Who we built this for
Genomic species identification has existed in research settings for decades, but the cost and infrastructure required to perform it has priced most customers out of the market. The farmers market vendor, the regional supplement brand with a single ingredient question, the individual buyer who wants to verify what they are putting in their body, the quality-conscious retailer looking for supply chain confidence: all of these customers have been outside the design parameters of commercial laboratory testing.
Lumicore exists to close that gap, and to bring enhanced resolution to larger enterprises seeking material and product species verification. Our pricing is structured around the actual cost of rigorous science, positioned to be accessible to the businesses and individuals who have had the least access to this kind of testing while supporting the needs of corporate customers as well.
How we work
Every sample that comes through our laboratory goes through internally validated protocols, is classified against reference databases we have built and tested in-house, and is reviewed before a report leaves the building. We control the full analytical workflow, from extraction through sequencing, bioinformatics, and interpretation, because keeping those steps under one roof is how we maintain the quality and scientific judgment that our work depends on.
Every report we produce documents the methodology, reference databases, sequencing platform, analytical pipeline, and basecalling parameters used to generate the result. A qualified scientist reading our report can evaluate exactly how we arrived at our conclusions and assess the methodology on its merits. Transparency in analytical methodology is a structural feature of how we operate.
We report what we find, and we report it completely. Some materials yield clean, confident identifications. Others yield ambiguous results, inconclusive signals, or recoverable DNA below our reporting threshold. All of those outcomes are documented honestly, because an accurate inconclusive finding serves a client better than a forced determination.
We see this work as infrastructure
Closing the gap between what biological verification can provide and what existing systems deliver is a longer project than any single company will complete. It requires analytical protocols that multiple laboratories can share, reference databases that improve as the underlying science improves, verification tools that ordinary people can actually use, and governance structures that prevent any single party from corrupting the system over time. Our architecture is designed deliberately to fit into that larger system as it develops.
Our underlying systems, developed in-house and protected by patent-pending technology, are designed around the principle that a verification record should remain trustworthy and independently confirmable long after it is generated, by anyone who needs to check it, without depending on any single institution to vouch for it. Our cryptographic verification layer is in active development, while the analytical workflow and service foundation is already in place.
When the full vision of an authentic and transparent market takes shape, verification at the molecular level becomes part of how biological commerce operates, something consumers and businesses recognize and expect as baseline. Lumicore succeeds when the question "how do you know what is in that?" has a clear, scientifically grounded answer that anyone can access.
What this means for you
Send us a sample, and we’ll tell you what is in it. You will receive a report documenting, at the genomic level, what species are present in the product you submitted, backed by methodology any scientist can evaluate. If your sample type or your verification question is something we haven’t addressed before, we’ll tell you honestly what is possible, and when we can build the capability your work requires, we’ll build it with you. The answer to 'what is this, actually?' should never depend on who you ask. The product already knows what it is. Our job is to read the answer and put it in your hands
bottom of page